Neuca S.A.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2001-10-15
Share capital
4,642,802.00 PLN
Activity description

Neuca is a listed company and a leader in pharmaceutical wholesale in Poland, supporting independent pharmacies. It also develops a patient-focused business under the Świat Zdrowia brand, covering medical facilities, imaging diagnostics centers and digital tools. The group also expands clinical trials activities and sustainability initiatives.

Registered address
ul. Forteczna 35-37, 87-100 Toruń, Poland
Email
Social media

Financials

Revenue history (in m)

Filing timeliness

Financial statements were filed on time, on average 57 days early. All were audited by a statutory auditor.

  • 202503/06/2026
  • 202408/07/2025
  • 202305/06/2024
  • 202220/06/2023
  • 202113/05/2022
  • 202006/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Stock quotes

PLN 705.00
-3.00 (-0.42%)
700.00705.00710.00715.00705.0010:0012:0014:0016:00
Open
PLN 714.00
High
PLN 714.00
Low
PLN 700.00
Volume
974
Avg. vol.
1.09K
Market cap
PLN 3.27B
P/E ratio
16.64
EPS
PLN 42.38
Shares outstanding
4.64M
52-week
PLN 678.00 – 714.00
Dividend yield
2.52%
Dividend
PLN 17.80
Ex dividend date
Jun 29, 2026
Exchange
GPW Main Market

Quarterly results

PeriodRevenueEBITNet profit
Q2 2026USD 964.59mUSD 17.79mUSD 11.02m
Q1 2026USD 960.81mUSD 26.12mUSD 18.46m
Q4 2025USD 884.19mUSD 13.60mUSD 6.81m
Q3 2025USD 876.15mUSD 19.72mUSD 15.13m

Results for Q3 2026:Nov 19, 2026

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top <1%
Division · Wholesale trade5 / 20,037
Top <1%
City · Toruń1 / 2,418
Top <1%
Voivodeship · Kujawsko-Pomorskie1 / 11,436
Top <1%
Country · Poland41 / 297,069
Top <1%

Results vs industry

Revenue
This companyUSD 3.44bnMedianUSD 1.08mAverageUSD 22.54m
Net profit
This companyUSD 39.14mMedianUSD 39.26kAverageUSD 885.01k
Operating costs
This companyUSD 3.36bnMedianUSD 963.92kAverageUSD 21.21m
Assets
This companyUSD 1.57bnMedianUSD 610.11kAverageUSD 11.92m

Offer

Websites

The company has 6 websites. Traffic on the sites is measured with Google Analytics.

  • apteline.plLeki, witaminy, suplementy diety, kosmetyki i dermokosmetyki | Apteline.pl
    MagentoGoogle Tag Manager
  • aptelink.plOdnajdywanie obszaru głównego
    Apache
  • atechconsulting.plA-TECH Consulting – zarządzanie projektami w budownictwie, nadzór inwestorski, inwestor zastępczy, inspektor
    Apache

Public procurement

1997 tenders recorded as contractor: 571 national ($23,571,596) and 1426 EU ($570,201,701).

SubjectAmount
Supply of various medicines, including programme medicines
–
Supply of medicines, lot 2
$4,437
Supply of medicines, lot 2
$300.1K

National Health Fund (NFZ) contracts

The company has been an NFZ healthcare provider since 2023. In 2026 it is performing 16 contracts with a total value of USD 0.00. All its contracts were worth USD 0.00 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Provision of medical devicesdolnośląskie1USD 0.00
Provision of medical deviceskujawsko-pomorskie1USD 0.00
Provision of medical deviceslubelskie1USD 0.00
Provision of medical deviceslubuskie1USD 0.00
Provision of medical devicesłódzkie1USD 0.00

Trademarks

The company holds 8 active trademarks registered with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2004.

MarkNumberClassesStatusProtected until
APTELINE ŚWIAT ZDROWIA Z.57245735, 38, 44Protected Jul 24, 2034
STACJA FARMACJA PODCAST Z.53426535, 38, 44Protected Sep 21, 2031
HeyDoc BLIŻEJ ZDROWIA Z.5196679, 10, 16, 35, 36, 38, 42, 44Protected Oct 19, 2030
SUPLINDEX Z.5028379, 16, 35, 44Protected Jul 29, 2029
NEUCA Zdrowe Innowacje (word)Z.4822775, 9, 10, 35, 41, 42, 44Protected Feb 12, 2028
MarkProtected until
APTELINE ŚWIAT ZDROWIA Jul 24, 2034
STACJA FARMACJA PODCAST Sep 21, 2031
HeyDoc BLIŻEJ ZDROWIA Oct 19, 2030
SUPLINDEX Jul 29, 2029
NEUCA Zdrowe Innowacje (word)Feb 12, 2028

Authorized Representatives

Aleksandra Wiesława Puskarz-Kusa age 56 – Attorney-in-fact (joint)
Daniel Artur Wojtkiewicz age 49 – Vice President of the Management Board
Julita Monika Czyżewska age 45 – Vice President of the Management Board
Dorota Katarzyna Kruszewska age 53 – Attorney-in-fact (joint)
Roman Dudzik age 49 – Vice President of the Management Board

Manner of representation

Two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, are authorized to submit declarations of will and represent the company.

Supervisory board

Piotr Borowski age 60 – Supervisory Board Member
Bożena Śliwa age 66 – Supervisory Board Member
Kazimierz Michał Herba age 61 – Supervisory Board Member
Wiesława Teresa Herba age 61 – Supervisory Board Member
Iwona Wanda Sierzputowska age 55 – Supervisory Board Member

Beneficial owners

Neuca is a public company listed on the Warsaw Stock Exchange, so it does not report beneficial owners to the CRBR (Art. 58 of the Polish AML Act). Its shareholders are disclosed in stock-exchange reports.

Subsidiaries

NameStake
Neuca Inwestycje sp. z o.o.
100%
100%
100%

Capital group

The company is the parent company of a corporate group. The group has 4 companies, 1 of them abroad.

NameOwnership
100%
Neuca Clinical Trials Investment Sp. z o.o.
100%
100%

Bank accounts

Was a VAT taxpayer from 1994-04-01 to 2024-10-31.

Reason for removal: Art. 96 ust. 7ba (deregistration of a VAT group member upon VAT group registration)

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Nov 20, 2023Commercial Companies Code notice

Public aid

5 public aid cases recorded, with a total value of $1,461,886.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
–
Aid for research and development projects: experimental development
–
Aid for research and development projects: industrial research
–

European Funds

2 projects recorded: 1 from FE lists ($1,411,569) and 1 Commission grant (FTS) ($0).

ProjectEU co-financing
Development of a process innovation in the form of a system designed for quality control processes related to the distribution of pharmaceuticals and other medical devices
$1.4M
Circularize value chains across european regional innovation strategies
$0

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
AZ Asset S.A.
Polska Grupa Farmaceutyczna S.A.
Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawex sp. z o.o.
Salus International sp. z o.o.
Hurtap S.A.
Medi&More sp. z o.o.
Novo S.A.
Przedsiębiorstwo Zaopatrzenia Aptek Multi Pharme S.A.
Producencka Centrala Farmaceutyczna Procefar sp. z o.o.
Lubfarm S.A.

Change history

DateEvent
2026-09-10Share capital increase
2026-04-16Share capital increase
2025-08-08Share capital increase
2025-06-10Share capital increase
2025-04-15Share capital increase

FAQ

Last updated: 2026-09-10